Incidence of acute pulmonary embolism among patients hospitalized with COVID-19: a systematic review and meta-analysis

Mohamed S. Munner; Charles A. Ritchie; Ibrahim H. Elkhidir; Doaa T. Mohammadat; Hussein J. Ahmed; Khalid A. Altayeb; Rawan Z. Yassin; Riyan M. Hassan; Saada A. Hamad; Mohammed Nimir; Osman S. Hamid; Margaret M. Johnson; Tathagat Narula; Young Erben; Rabih G. Tawk; David A. Miller; Vivek Gupta; Zlatko Devcic; William D Freeman; Beau B. Toskich

doi:10.12688/f1000research.27425.2

Incidence of acute pulmonary embolism among patients hospitalized with COVID-19: a systematic review and meta-analysis

Mohamed S. Munner, Charles A. Ritchie, Ibrahim H. Elkhidir, Doaa T. Mohammadat, Hussein J. Ahmed, Khalid A. Altayeb, Rawan Z. Yassin, Riyan M. Hassan, Saada A. Hamad, Mohammed Nimir, Osman S. Hamid, Margaret M. Johnson, Tathagat Narula, Young Erben, Rabih G. Tawk, David A. Miller, Vivek Gupta, Zlatko Devcic, William D Freeman, Beau B. Toskich

Research output: Contribution to journal › Review article › peer-review

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a global pandemic, which is associated with venous thromboembolism and pulmonary embolism (PE). This study aimed to estimate the pooled incidence of PE among patients hospitalized with COVID-19 within the published literature. Methods: This systematic review and meta-analysis was performed according to PRISMA guidelines. An electronic search using MEDLINE /PubMed, ScienceDirect, Cochrane, and OpenGray databases was conducted May 19th, 2020. Eligible studies included sufficient data to calculate the incidence of PE diagnosed during hospitalization in patients with COVID-19. Case reports were excluded. Quality was assessed using the Newcastle-Ottawa scale (observational cohort and case-control), AXIS tool (cross-sectional), and quality assessment tool (case series). Demographics and PE incidence data were extracted from the included studies and analyzed with R language. The pooled incidence of PE in patients hospitalized with COVID-19 was calculated. Results: The database search identified 128 records. Ten observational studies were eligible and were included in the meta-analysis with a total of 1722 patients (mean age= 63.36).The incidence of PE was noted to be higher in males. The D-dimer levels were specified between PE group and non-PE group in only three studies, while the remaining either reported it improperly or had missing data.The pooled PE incidence in patients hospitalized with COVID-19 was 17% (95% CI: 0.1-0.26). There was a high degree of study heterogeneity (I2 = 94%, p<0.01). Conclusion: The pooled PE incidence in patients hospitalized with COVID-19 is 17%. This increased incidence is greater than that previously reported in the general population of non-COVID-19. Attention and further investigation of this risk is warranted.

Original language	English (US)
Article number	1489
Journal	F1000Research
Volume	9
DOIs	https://doi.org/10.12688/f1000research.27425.2
State	Published - 2021

Keywords

Coronavirus
COVID-19
Incidence
Meta-analysis
Pulmonary Embolism
Venous thromboembolism

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Immunology and Microbiology(all)
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.12688/f1000research.27425.2

Cite this

Munner, M. S., Ritchie, C. A., Elkhidir, I. H., Mohammadat, D. T., Ahmed, H. J., Altayeb, K. A., Yassin, R. Z., Hassan, R. M., Hamad, S. A., Nimir, M., Hamid, O. S., Johnson, M. M., Narula, T., Erben, Y., Tawk, R. G., Miller, D. A., Gupta, V., Devcic, Z., Freeman, W. D., & Toskich, B. B. (2021). Incidence of acute pulmonary embolism among patients hospitalized with COVID-19: a systematic review and meta-analysis. F1000Research, 9, [1489]. https://doi.org/10.12688/f1000research.27425.2

Munner, MS, Ritchie, CA, Elkhidir, IH, Mohammadat, DT, Ahmed, HJ, Altayeb, KA, Yassin, RZ, Hassan, RM, Hamad, SA, Nimir, M, Hamid, OS, Johnson, MM, Narula, T, Erben, Y, Tawk, RG, Miller, DA, Gupta, V, Devcic, Z, Freeman, WD & Toskich, BB 2021, 'Incidence of acute pulmonary embolism among patients hospitalized with COVID-19: a systematic review and meta-analysis', F1000Research, vol. 9, 1489. https://doi.org/10.12688/f1000research.27425.2

@article{f94b80dabf234703896db4e8a76b3d27,

title = "Incidence of acute pulmonary embolism among patients hospitalized with COVID-19: a systematic review and meta-analysis",

abstract = "Background: Coronavirus disease 2019 (COVID-19) is a global pandemic, which is associated with venous thromboembolism and pulmonary embolism (PE). This study aimed to estimate the pooled incidence of PE among patients hospitalized with COVID-19 within the published literature. Methods: This systematic review and meta-analysis was performed according to PRISMA guidelines. An electronic search using MEDLINE /PubMed, ScienceDirect, Cochrane, and OpenGray databases was conducted May 19th, 2020. Eligible studies included sufficient data to calculate the incidence of PE diagnosed during hospitalization in patients with COVID-19. Case reports were excluded. Quality was assessed using the Newcastle-Ottawa scale (observational cohort and case-control), AXIS tool (cross-sectional), and quality assessment tool (case series). Demographics and PE incidence data were extracted from the included studies and analyzed with R language. The pooled incidence of PE in patients hospitalized with COVID-19 was calculated. Results: The database search identified 128 records. Ten observational studies were eligible and were included in the meta-analysis with a total of 1722 patients (mean age= 63.36).The incidence of PE was noted to be higher in males. The D-dimer levels were specified between PE group and non-PE group in only three studies, while the remaining either reported it improperly or had missing data.The pooled PE incidence in patients hospitalized with COVID-19 was 17% (95% CI: 0.1-0.26). There was a high degree of study heterogeneity (I2 = 94%, p<0.01). Conclusion: The pooled PE incidence in patients hospitalized with COVID-19 is 17%. This increased incidence is greater than that previously reported in the general population of non-COVID-19. Attention and further investigation of this risk is warranted.",

keywords = "Coronavirus, COVID-19, Incidence, Meta-analysis, Pulmonary Embolism, Venous thromboembolism",

author = "Munner, {Mohamed S.} and Ritchie, {Charles A.} and Elkhidir, {Ibrahim H.} and Mohammadat, {Doaa T.} and Ahmed, {Hussein J.} and Altayeb, {Khalid A.} and Yassin, {Rawan Z.} and Hassan, {Riyan M.} and Hamad, {Saada A.} and Mohammed Nimir and Hamid, {Osman S.} and Johnson, {Margaret M.} and Tathagat Narula and Young Erben and Tawk, {Rabih G.} and Miller, {David A.} and Vivek Gupta and Zlatko Devcic and Freeman, {William D} and Toskich, {Beau B.}",

note = "Publisher Copyright: Copyright: {\textcopyright} 2021 Munner MS et al.",

year = "2021",

doi = "10.12688/f1000research.27425.2",

language = "English (US)",

volume = "9",

journal = "F1000Research",

issn = "2046-1402",

publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Incidence of acute pulmonary embolism among patients hospitalized with COVID-19

T2 - a systematic review and meta-analysis

AU - Munner, Mohamed S.

AU - Ritchie, Charles A.

AU - Elkhidir, Ibrahim H.

AU - Mohammadat, Doaa T.

AU - Ahmed, Hussein J.

AU - Altayeb, Khalid A.

AU - Yassin, Rawan Z.

AU - Hassan, Riyan M.

AU - Hamad, Saada A.

AU - Nimir, Mohammed

AU - Hamid, Osman S.

AU - Johnson, Margaret M.

AU - Narula, Tathagat

AU - Erben, Young

AU - Tawk, Rabih G.

AU - Miller, David A.

AU - Gupta, Vivek

AU - Devcic, Zlatko

AU - Freeman, William D

AU - Toskich, Beau B.

PY - 2021

Y1 - 2021

N2 - Background: Coronavirus disease 2019 (COVID-19) is a global pandemic, which is associated with venous thromboembolism and pulmonary embolism (PE). This study aimed to estimate the pooled incidence of PE among patients hospitalized with COVID-19 within the published literature. Methods: This systematic review and meta-analysis was performed according to PRISMA guidelines. An electronic search using MEDLINE /PubMed, ScienceDirect, Cochrane, and OpenGray databases was conducted May 19th, 2020. Eligible studies included sufficient data to calculate the incidence of PE diagnosed during hospitalization in patients with COVID-19. Case reports were excluded. Quality was assessed using the Newcastle-Ottawa scale (observational cohort and case-control), AXIS tool (cross-sectional), and quality assessment tool (case series). Demographics and PE incidence data were extracted from the included studies and analyzed with R language. The pooled incidence of PE in patients hospitalized with COVID-19 was calculated. Results: The database search identified 128 records. Ten observational studies were eligible and were included in the meta-analysis with a total of 1722 patients (mean age= 63.36).The incidence of PE was noted to be higher in males. The D-dimer levels were specified between PE group and non-PE group in only three studies, while the remaining either reported it improperly or had missing data.The pooled PE incidence in patients hospitalized with COVID-19 was 17% (95% CI: 0.1-0.26). There was a high degree of study heterogeneity (I2 = 94%, p<0.01). Conclusion: The pooled PE incidence in patients hospitalized with COVID-19 is 17%. This increased incidence is greater than that previously reported in the general population of non-COVID-19. Attention and further investigation of this risk is warranted.

AB - Background: Coronavirus disease 2019 (COVID-19) is a global pandemic, which is associated with venous thromboembolism and pulmonary embolism (PE). This study aimed to estimate the pooled incidence of PE among patients hospitalized with COVID-19 within the published literature. Methods: This systematic review and meta-analysis was performed according to PRISMA guidelines. An electronic search using MEDLINE /PubMed, ScienceDirect, Cochrane, and OpenGray databases was conducted May 19th, 2020. Eligible studies included sufficient data to calculate the incidence of PE diagnosed during hospitalization in patients with COVID-19. Case reports were excluded. Quality was assessed using the Newcastle-Ottawa scale (observational cohort and case-control), AXIS tool (cross-sectional), and quality assessment tool (case series). Demographics and PE incidence data were extracted from the included studies and analyzed with R language. The pooled incidence of PE in patients hospitalized with COVID-19 was calculated. Results: The database search identified 128 records. Ten observational studies were eligible and were included in the meta-analysis with a total of 1722 patients (mean age= 63.36).The incidence of PE was noted to be higher in males. The D-dimer levels were specified between PE group and non-PE group in only three studies, while the remaining either reported it improperly or had missing data.The pooled PE incidence in patients hospitalized with COVID-19 was 17% (95% CI: 0.1-0.26). There was a high degree of study heterogeneity (I2 = 94%, p<0.01). Conclusion: The pooled PE incidence in patients hospitalized with COVID-19 is 17%. This increased incidence is greater than that previously reported in the general population of non-COVID-19. Attention and further investigation of this risk is warranted.

KW - Coronavirus

KW - COVID-19

KW - Incidence

KW - Meta-analysis

KW - Pulmonary Embolism

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85121375641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121375641&partnerID=8YFLogxK

U2 - 10.12688/f1000research.27425.2

DO - 10.12688/f1000research.27425.2

M3 - Review article

AN - SCOPUS:85121375641

SN - 2046-1402

VL - 9

JO - F1000Research

JF - F1000Research

M1 - 1489

ER -

Incidence of acute pulmonary embolism among patients hospitalized with COVID-19: a systematic review and meta-analysis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this